USANA Health Sciences Inc当前公司基本面数据相对非常健康,增长潜力较大。当前估值合理,在食品与烟草行业排名68/96位。机构持股占比非常高,近一月多位分析师给出公司评级为。最高目标价39.00。中期看,股价处于下降通道。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。
USANA Health Sciences Inc评分
相关信息
行业排名
68 / 96
全市场排名
372 / 4578
所属行业
食品与烟草
压力支撑
由于公司未披露,未能获取相关数据
多维评测
本期评分
上期评分
分析师目标
根据
0
位分析师
--
评级
39.000
目标均价
+100.93%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议
USANA Health Sciences Inc亮点
亮点风险
USANA Health Sciences, Inc. and subsidiaries is a global nutrition, personal health and wellness company that develops and manufactures science-based nutritional and personal care products. Its segments include Direct selling and Hiya direct-to-consumer. The Direct Selling segment develops and manufactures science-based nutritional, personal care and skincare products with a primary focus on promoting long-term health and wellness in various geographic markets worldwide that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children’s health and wellness products in the United States that are distributed through the direct-to-consumer channel. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, and Foods. USANA Nutritionals Optimizers products include Proflavanol, CoQuinone 30, and BiOmega-3. Essentials/CellSentials products include USANA CellSentials and HealthPak 100.
USANA Health Sciences, Inc. and subsidiaries is a global nutrition, personal health and wellness company that develops and manufactures science-based nutritional and personal care products. Its segments include Direct selling and Hiya direct-to-consumer. The Direct Selling segment develops and manufactures science-based nutritional, personal care and skincare products with a primary focus on promoting long-term health and wellness in various geographic markets worldwide that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children’s health and wellness products in the United States that are distributed through the direct-to-consumer channel. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, and Foods. USANA Nutritionals Optimizers products include Proflavanol, CoQuinone 30, and BiOmega-3. Essentials/CellSentials products include USANA CellSentials and HealthPak 100.
公司代码USNA
公司USANA Health Sciences Inc
CEOBrown (Jim H)
网址https://www.usana.com/
常见问题
USANA Health Sciences Inc(USNA)的当前股价是多少?
USANA Health Sciences Inc(USNA)的当前股价是 19.620。
USANA Health Sciences Inc的股票代码是什么?
USANA Health Sciences Inc的股票代码是USNA。
USANA Health Sciences Inc股票的52周最高点是多少?
USANA Health Sciences Inc股票的52周最高点是38.320。
USANA Health Sciences Inc股票的52周最低点是多少?
USANA Health Sciences Inc股票的52周最低点是18.480。
USANA Health Sciences Inc的市值是多少?
USANA Health Sciences Inc的市值是358.50M。
USANA Health Sciences Inc的净利润是多少?
USANA Health Sciences Inc的净利润为42.03M。
现在USANA Health Sciences Inc(USNA)的股票是买入、持有还是卖出?
根据分析师评级,USANA Health Sciences Inc(USNA)的总体评级为--,目标价格为39.000。
USANA Health Sciences Inc(USNA)股票的每股收益(EPS TTM)是多少
USANA Health Sciences Inc(USNA)股票的每股收益(EPS TTM)是0.907。